Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Alterity Therapeutics Ltd. ( (AU:ATH) ).
Alterity Therapeutics Ltd. has announced the quotation of 164,242,200 fully paid ordinary securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and signifies Alterity’s ongoing efforts to bolster its financial standing and enhance its market presence.
More about Alterity Therapeutics Ltd.
Alterity Therapeutics Ltd. operates in the biotechnology industry, focusing on the development of therapies for neurodegenerative diseases.
YTD Price Performance: 0%
Average Trading Volume: 100
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $39.1M
Find detailed analytics on ATH stock on TipRanks’ Stock Analysis page.